201 related articles for article (PubMed ID: 38117803)
1. Image-localized biopsy mapping of brain tumor heterogeneity: A single-center study protocol.
Urcuyo JC; Curtin L; Langworthy JM; De Leon G; Anderies B; Singleton KW; Hawkins-Daarud A; Jackson PR; Bond KM; Ranjbar S; Lassiter-Morris Y; Clark-Swanson KR; Paulson LE; Sereduk C; Mrugala MM; Porter AB; Baxter L; Salomao M; Donev K; Hudson M; Meyer J; Zeeshan Q; Sattur M; Patra DP; Jones BA; Rahme RJ; Neal MT; Patel N; Kouloumberis P; Turkmani AH; Lyons M; Krishna C; Zimmerman RS; Bendok BR; Tran NL; Hu LS; Swanson KR
PLoS One; 2023; 18(12):e0287767. PubMed ID: 38117803
[TBL] [Abstract][Full Text] [Related]
2. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
3. A Cellular Ground Truth to Develop MRI Signatures in Glioma Models by Correlative Light Sheet Microscopy and Atlas-Based Coregistration.
Schregel K; Heinz L; Hunger J; Pan C; Bode J; Fischer M; Sturm V; Venkataramani V; Karimian-Jazi K; Agardy DA; Streibel Y; Zerelles R; Wick W; Heiland S; Bunse T; Tews B; Platten M; Winkler F; Bendszus M; Breckwoldt MO
J Neurosci; 2023 Jul; 43(30):5574-5587. PubMed ID: 37429718
[TBL] [Abstract][Full Text] [Related]
4. Associations between clinical outcome and navigated transcranial magnetic stimulation characteristics in patients with motor-eloquent brain lesions: a combined navigated transcranial magnetic stimulation-diffusion tensor imaging fiber tracking approach.
Sollmann N; Wildschuetz N; Kelm A; Conway N; Moser T; Bulubas L; Kirschke JS; Meyer B; Krieg SM
J Neurosurg; 2018 Mar; 128(3):800-810. PubMed ID: 28362239
[TBL] [Abstract][Full Text] [Related]
5. Comparison of unsupervised classification methods for brain tumor segmentation using multi-parametric MRI.
Sauwen N; Acou M; Van Cauter S; Sima DM; Veraart J; Maes F; Himmelreich U; Achten E; Van Huffel S
Neuroimage Clin; 2016; 12():753-764. PubMed ID: 27812502
[TBL] [Abstract][Full Text] [Related]
6. Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements.
Hu LS; Baxter LC; Smith KA; Feuerstein BG; Karis JP; Eschbacher JM; Coons SW; Nakaji P; Yeh RF; Debbins J; Heiserman JE
AJNR Am J Neuroradiol; 2009 Mar; 30(3):552-8. PubMed ID: 19056837
[TBL] [Abstract][Full Text] [Related]
7. Imaging biomarker analysis of advanced multiparametric MRI for glioma grading.
Vamvakas A; Williams SC; Theodorou K; Kapsalaki E; Fountas K; Kappas C; Vassiou K; Tsougos I
Phys Med; 2019 Apr; 60():188-198. PubMed ID: 30910431
[TBL] [Abstract][Full Text] [Related]
8. Introduction of a standardized multimodality image protocol for navigation-guided surgery of suspected low-grade gliomas.
Mert A; Kiesel B; Wöhrer A; Martínez-Moreno M; Minchev G; Furtner J; Knosp E; Wolfsberger S; Widhalm G
Neurosurg Focus; 2015 Jan; 38(1):E4. PubMed ID: 25552284
[TBL] [Abstract][Full Text] [Related]
9. An MRS- and PET-guided biopsy tool for intraoperative neuronavigational systems.
Grech-Sollars M; Vaqas B; Thompson G; Barwick T; Honeyfield L; O'Neill K; Waldman AD
J Neurosurg; 2017 Oct; 127(4):812-818. PubMed ID: 27834593
[TBL] [Abstract][Full Text] [Related]
10. Biopsy targeting with dynamic contrast-enhanced versus standard neuronavigation MRI in glioma: a prospective double-blinded evaluation of selection benefits.
Keil VC; Pintea B; Gielen GH; Greschus S; Fimmers R; Gieseke J; Simon M; Schild HH; Hadizadeh DR
J Neurooncol; 2017 May; 133(1):155-163. PubMed ID: 28425048
[TBL] [Abstract][Full Text] [Related]
11. Modern preoperative imaging and functional mapping in patients with intracranial glioma.
Sollmann N; Zhang H; Kloth C; Zimmer C; Wiestler B; Rosskopf J; Kreiser K; Schmitz B; Beer M; Krieg SM
Rofo; 2023 Nov; 195(11):989-1000. PubMed ID: 37224867
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity Diffusion Imaging of gliomas: Initial experience and validation.
Wang Q; Pérez-Carrillo GJG; Ponisio MR; LaMontagne P; Dahiya S; Marcus DS; Milchenko M; Shimony J; Liu J; Chen G; Salter A; Massoumzadeh P; Miller-Thomas MM; Rich KM; McConathy J; Benzinger TLS; Wang Y
PLoS One; 2019; 14(11):e0225093. PubMed ID: 31725772
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Diffusion Tensor Imaging and Magnetic Resonance Perfusion Imaging in Differentiating Recurrent Brain Neoplasm From Radiation Necrosis.
Masch WR; Wang PI; Chenevert TL; Junck L; Tsien C; Heth JA; Sundgren PC
Acad Radiol; 2016 May; 23(5):569-76. PubMed ID: 26916251
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
[TBL] [Abstract][Full Text] [Related]
15. Guiding the first biopsy in glioma patients using estimated Ki-67 maps derived from MRI: conventional versus advanced imaging.
Gates EDH; Lin JS; Weinberg JS; Hamilton J; Prabhu SS; Hazle JD; Fuller GN; Baladandayuthapani V; Fuentes D; Schellingerhout D
Neuro Oncol; 2019 Mar; 21(4):527-536. PubMed ID: 30657997
[TBL] [Abstract][Full Text] [Related]
16. Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures.
Hu LS; D'Angelo F; Weiskittel TM; Caruso FP; Fortin Ensign SP; Blomquist MR; Flick MJ; Wang L; Sereduk CP; Meng-Lin K; De Leon G; Nespodzany A; Urcuyo JC; Gonzales AC; Curtin L; Lewis EM; Singleton KW; Dondlinger T; Anil A; Semmineh NB; Noviello T; Patel RA; Wang P; Wang J; Eschbacher JM; Hawkins-Daarud A; Jackson PR; Grunfeld IS; Elrod C; Mazza GL; McGee SC; Paulson L; Clark-Swanson K; Lassiter-Morris Y; Smith KA; Nakaji P; Bendok BR; Zimmerman RS; Krishna C; Patra DP; Patel NP; Lyons M; Neal M; Donev K; Mrugala MM; Porter AB; Beeman SC; Jensen TR; Schmainda KM; Zhou Y; Baxter LC; Plaisier CL; Li J; Li H; Lasorella A; Quarles CC; Swanson KR; Ceccarelli M; Iavarone A; Tran NL
Nat Commun; 2023 Sep; 14(1):6066. PubMed ID: 37770427
[TBL] [Abstract][Full Text] [Related]
17. Hierarchical non-negative matrix factorization to characterize brain tumor heterogeneity using multi-parametric MRI.
Sauwen N; Sima DM; Van Cauter S; Veraart J; Leemans A; Maes F; Himmelreich U; Van Huffel S
NMR Biomed; 2015 Dec; 28(12):1599-624. PubMed ID: 26458729
[TBL] [Abstract][Full Text] [Related]
18. Estimating Local Cellular Density in Glioma Using MR Imaging Data.
Gates EDH; Weinberg JS; Prabhu SS; Lin JS; Hamilton J; Hazle JD; Fuller GN; Baladandayuthapani V; Fuentes DT; Schellingerhout D
AJNR Am J Neuroradiol; 2021 Jan; 42(1):102-108. PubMed ID: 33243897
[TBL] [Abstract][Full Text] [Related]
19. Influence of 1.5-Tesla intraoperative MR imaging on surgical decision making.
Hall WA; Liu H; Maxwell RE; Truwit CL
Acta Neurochir Suppl; 2003; 85():29-37. PubMed ID: 12570135
[TBL] [Abstract][Full Text] [Related]
20. Improved delineation of glioma margins and regions of infiltration with the use of diffusion tensor imaging: an image-guided biopsy study.
Price SJ; Jena R; Burnet NG; Hutchinson PJ; Dean AF; Peña A; Pickard JD; Carpenter TA; Gillard JH
AJNR Am J Neuroradiol; 2006 Oct; 27(9):1969-74. PubMed ID: 17032877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
